AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35263280 — intervention group
Group type: COMPARATOR
Intervention: Intranasal oxygen administration
Number of subjects: 6
Study 34536433 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance ergometer cycling (EC)
Number of subjects: 64
Study 34536433 — intervention group
Group type: EXPERIMENTAL
Intervention: Muscle strengthening whole body vibration (WBV)
Number of subjects: 64
Study 34536433 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 64
Study 34119270 — intervention group
Group type: COMPARATOR
Intervention: Aspirin alone
Number of subjects: 1102
Study 34119270 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined cilostazol and aspirin therapy
Number of subjects: 1102
Study 32179965 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-hour basic training program for RA patients
Number of subjects: 249
Study 32179965 — intervention group
Group type: COMPARATOR
Intervention: Waiting control group
Number of subjects: 249
Study 35752566 — intervention group
Group type: EXPERIMENTAL
Intervention: iGlarLixi
Number of subjects: 104
Study 35752566 — intervention group
Group type: COMPARATOR
Intervention: iGlar + gliclazide
Number of subjects: 104
Study 33452064 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic hypothermia for HIE
Number of subjects: 486
Study 33452064 — intervention group
Group type: EXPERIMENTAL
Intervention: Early model variables (HIE severity, epinephrine administration, respiratory support, fraction of inspired oxygen of 0.21 at admission)
Number of subjects: 486
Study 33452064 — intervention group
Group type: EXPERIMENTAL
Intervention: Cumulative model variables (Severity of EEG findings, HIE severity, use of steroids for blood pressure management, significant brain injury on MRI)
Number of subjects: 486
Study 33452064 — intervention group
Group type: EXPERIMENTAL
Intervention: Early model
Number of subjects: 486
Study 33452064 — intervention group
Group type: EXPERIMENTAL
Intervention: Cumulative model
Number of subjects: 486
Study 33452064 — intervention group
Group type: EXPERIMENTAL
Intervention: Validation cohort
Number of subjects: 486
Study 34215800 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical capsaicin applied to the left upper back
Number of subjects: 20
Study 34215800 — intervention group
Group type: COMPARATOR
Intervention: Placebo topical cream applied to the left upper back
Number of subjects: 20
Study 32122449 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D₃ deficiency group (serum 25-OH vitamin D₃ levels low)
Number of subjects: 100
Study 32122449 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D₃ deficiency group
Number of subjects: 100
Study 32122449 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy subjects)
Number of subjects: 100
Study 36303113 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-linear periodized aerobic exercise (NLPE) for 8 weeks (n = 28)
Number of subjects: 43
Study 36303113 — intervention group
Group type: COMPARATOR
Intervention: Standard exercise recommendations (n = 15)
Number of subjects: 43
Study 36303113 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-linear periodized aerobic exercise (NLPE)
Number of subjects: 43
Study 33168545 — intervention group
Group type: EXPERIMENTAL
Intervention: Abatacept 125 mg weekly subcutaneous for 169 days
Number of subjects: 187
Study 33168545 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 187
Study 32014238 — intervention group
Group type: EXPERIMENTAL
Intervention: Participant-controlled intravenous rehydration with 4% dextrose in 0.18% sodium chloride, bolus volumes of 50 ml (low volume) or 200 ml (high volume), triggered by thirst.
Number of subjects: 10
Study 35575148 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional exercise training
Number of subjects: 0
Study 35575148 — intervention group
Group type: EXPERIMENTAL
Intervention: High-load inspiratory muscle training (IMT)
Number of subjects: 0
Study 35575148 — intervention group
Group type: COMPARATOR
Intervention: Low-load inspiratory muscle training (IMT)
Number of subjects: 0
Study 35575148 — intervention group
Group type: COMPARATOR
Intervention: No inspiratory muscle training (IMT)
Number of subjects: 0
Study 35575148 — intervention group
Group type: EXPERIMENTAL
Intervention: Gluteal muscle size
Number of subjects: 0
Study 33532898 — intervention group
Group type: EXPERIMENTAL
Intervention: Double Reverse Traction Repositor (DRTR)
Number of subjects: 77
Study 33532898 — intervention group
Group type: COMPARATOR
Intervention: Manual Traction (MT)
Number of subjects: 77
Study 33287395 — intervention group
Group type: EXPERIMENTAL
Intervention: Price promotions on unhealthy foods at end of aisles
Number of subjects: 104
Study 33287395 — intervention group
Group type: EXPERIMENTAL
Intervention: Price promotions on unhealthy foods at island bins
Number of subjects: 104
Study 33287395 — intervention group
Group type: EXPERIMENTAL
Intervention: Price promotions on unhealthy foods at checkouts
Number of subjects: 104
Study 33287395 — intervention group
Group type: COMPARATOR
Intervention: Price promotions on healthy foods
Number of subjects: 104
Study 35872962 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive transcatheter closure under the guidance of transesophageal ultrasound
Number of subjects: 100
Study 35872962 — intervention group
Group type: COMPARATOR
Intervention: Minimally invasive transcatheter closure under the guidance of X-ray
Number of subjects: 100
Study 32976660 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg piroxicam
Number of subjects: 160
Study 32976660 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg prednisolone
Number of subjects: 160
Study 32976660 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mg dexamethasone
Number of subjects: 160
Study 32976660 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160
Study 33511868 — intervention group
Group type: EXPERIMENTAL
Intervention: Quickcast orthosis
Number of subjects: 58
Study 33511868 — intervention group
Group type: COMPARATOR
Intervention: Orfilight thermoplastic custom‐fabricated orthosis
Number of subjects: 58
Study 33511868 — intervention group
Group type: EXPERIMENTAL
Intervention: Quickcast orthosis (soft tissue mallet group)
Number of subjects: 58
Study 33511868 — intervention group
Group type: COMPARATOR
Intervention: Orfilight thermoplastic custom‐fabricated orthosis (soft tissue mallet group)
Number of subjects: 58
Study 33511868 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 58
Study 34671619 — intervention group
Group type: EXPERIMENTAL
Intervention: Balanced crystalloids
Number of subjects: 0
Study 34671619 — intervention group
Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 0
Study 32635408 — intervention group
Group type: EXPERIMENTAL
Intervention: Heat-killed Pediococcus acidilactici K15 (5 × 10^10 bacteria)
Number of subjects: 172
Study 32635408 — intervention group
Group type: COMPARATOR
Intervention: Dextrin (placebo)
Number of subjects: 172
Study 32635408 — intervention group
Group type: EXPERIMENTAL
Intervention: Heat-killed Pediococcus acidilactici K15
Number of subjects: 172
Study 35219633 — intervention group
Group type: EXPERIMENTAL
Intervention: Conflict Analysis (CA)
Number of subjects: 12
Study 35219633 — intervention group
Group type: COMPARATOR
Intervention: Mindfulness (Control)
Number of subjects: 12
Study 32993464 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiographic Core Laboratory (ACL) analysis
Number of subjects: 50
Study 32993464 — intervention group
Group type: COMPARATOR
Intervention: Cardiovascular Imaging Core Laboratory (CICL) analysis
Number of subjects: 50
Study 32993464 — intervention group
Group type: COMPARATOR
Intervention: Inter-core laboratory analysis
Number of subjects: 50
Study 32993464 — intervention group
Group type: COMPARATOR
Intervention: Bland-Altman analysis for pre-MLD
Number of subjects: 50
Study 32993464 — intervention group
Group type: COMPARATOR
Intervention: Bland-Altman analysis for stent MLD
Number of subjects: 50
Study 32993464 — intervention group
Group type: COMPARATOR
Intervention: Bland-Altman analysis for acute gain
Number of subjects: 50
Study 32993464 — intervention group
Group type: COMPARATOR
Intervention: Bland-Altman analysis for late loss
Number of subjects: 50
Study 32993464 — intervention group
Group type: COMPARATOR
Intervention: CICL analysis for pre-MLD
Number of subjects: 50
Study 32993464 — intervention group
Group type: COMPARATOR
Intervention: CICL analysis for stent MLD
Number of subjects: 50
Study 32993464 — intervention group
Group type: COMPARATOR
Intervention: CICL analysis for acute gain
Number of subjects: 50
Study 32993464 — intervention group
Group type: COMPARATOR
Intervention: CICL analysis for late loss
Number of subjects: 50
Study 32993464 — intervention group
Group type: COMPARATOR
Intervention: Coefficient of variation in lesion length, acute gain, late loss, and loss index
Number of subjects: 50
Study 36228777 — intervention group
Group type: EXPERIMENTAL
Intervention: Medications-first arm
Number of subjects: 453
Study 36228777 — intervention group
Group type: COMPARATOR
Intervention: Trabeculectomy-first arm
Number of subjects: 453
Study 34174842 — intervention group
Group type: EXPERIMENTAL
Intervention: Carnosine (2 g/day)
Number of subjects: 40
Study 34174842 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 33723973 — intervention group
Group type: EXPERIMENTAL
Intervention: Stachys sieboldii Miq granules
Number of subjects: 120
Study 33723973 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 33588822 — intervention group
Group type: EXPERIMENTAL
Intervention: Unsupervised, Supported
Number of subjects: 54
Study 33588822 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised, Supported
Number of subjects: 54
Study 33588822 — intervention group
Group type: COMPARATOR
Intervention: Unsupervised, Unsupported
Number of subjects: 54
Study 36184621 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid trial design using external control datasets and randomization
Number of subjects: 0
Study 36184621 — intervention group
Group type: COMPARATOR
Intervention: Externally controlled trials
Number of subjects: 0
Study 36184621 — intervention group
Group type: COMPARATOR
Intervention: Randomized trial designs
Number of subjects: 0
Study 32405735 — intervention group
Group type: EXPERIMENTAL
Intervention: PSMA-guided radiotherapy
Number of subjects: 86
Study 32405735 — intervention group
Group type: EXPERIMENTAL
Intervention: PSMA-guided radiotherapy with concomitant ADT or more than 24 fractions of radiation
Number of subjects: 86
Study 32791950 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive lipid-lowering therapy (ILLT) comprising single LDL apheresis and statins
Number of subjects: 160
Study 32791950 — intervention group
Group type: COMPARATOR
Intervention: Standard medical therapy (SMT) with no LDL apheresis and statin therapy alone
Number of subjects: 160
Study 32791950 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive lipid-lowering therapy (ILLT)
Number of subjects: 160
Study 32791950 — intervention group
Group type: COMPARATOR
Intervention: Standard medical therapy (SMT)
Number of subjects: 160
Study 36184349 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryoballoon ablation (group 1)
Number of subjects: 127
Study 36184349 — intervention group
Group type: COMPARATOR
Intervention: Radiofrequency ablation (group 2)
Number of subjects: 127
Study 33581956 — intervention group
Group type: EXPERIMENTAL
Intervention: Posterior bending osteotomy
Number of subjects: 38
Study 33581956 — intervention group
Group type: COMPARATOR
Intervention: Grinding
Number of subjects: 38
Study 34525901 — intervention group
Group type: EXPERIMENTAL
Intervention: Dry needling
Number of subjects: 60
Study 34525901 — intervention group
Group type: COMPARATOR
Intervention: Sham dry needling
Number of subjects: 60
Study 33592034 — intervention group
Group type: EXPERIMENTAL
Intervention: High Dimensional Selection with Interactions (HDSI) algorithm
Number of subjects: 0
Study 33592034 — intervention group
Group type: COMPARATOR
Intervention: LASSO, subset selection, adaptive LASSO, random LASSO, group LASSO
Number of subjects: 0
Study 34986012 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Laser Therapy (HILT), 1500 mJ/cm2, three sessions/week for 4 weeks
Number of subjects: 40
Study 34986012 — intervention group
Group type: COMPARATOR
Intervention: Extracorporeal Shock Wave Therapy (ESWT), 0.05 mJ/mm2, one session/week for 4 weeks
Number of subjects: 40
Study 32437192 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine 1 mg/kg
Number of subjects: 31
Study 32437192 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine 3 mg/kg
Number of subjects: 31
Study 32437192 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study 32192292 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified tubal resection or ligation
Number of subjects: 86
Study 32192292 — intervention group
Group type: COMPARATOR
Intervention: Traditional tubal resection or ligation
Number of subjects: 86
Study 34749275 — intervention group
Group type: EXPERIMENTAL
Intervention: Women's‐children's rights online course (14-week duration)
Number of subjects: 62
Study 34749275 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 62
Study 32780096 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-aided indirect bonding
Number of subjects: 37
Study 32780096 — intervention group
Group type: COMPARATOR
Intervention: Direct bonding
Number of subjects: 37
Study 35485674 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega 3 (flaxseed oil) 1gm three times daily for 3 months
Number of subjects: 48
Study 35485674 — intervention group
Group type: COMPARATOR
Intervention: Placebo (lactose capsule) for 3 months
Number of subjects: 48
Study 32495298 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-year hip osteoporotic fracture probability
Number of subjects: 264
Study 32495298 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-year major osteoporotic fracture probability
Number of subjects: 264
Study 32495298 — intervention group
Group type: COMPARATOR
Intervention: Guideline-recommended threshold for 10-year hip osteoporotic fracture
Number of subjects: 264
Study 32495298 — intervention group
Group type: COMPARATOR
Intervention: Guideline-recommended threshold for 10-year major osteoporotic fracture
Number of subjects: 264
Study 33350776 — intervention group
Group type: EXPERIMENTAL
Intervention: Nursing case management
Number of subjects: 200
Study 35466954 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital health technologies (DHTs) as secondary/exploratory outcome measures
Number of subjects: 0
Study 35466954 — intervention group
Group type: COMPARATOR
Intervention: Traditional outcome measures
Number of subjects: 0
Study 33998818 — intervention group
Group type: EXPERIMENTAL
Intervention: Exergame cognitive training with active tRNS stimulation
Number of subjects: 49
Study 33998818 — intervention group
Group type: COMPARATOR
Intervention: Exergame cognitive training with sham tRNS stimulation
Number of subjects: 49
Study 33998818 — intervention group
Group type: COMPARATOR
Intervention: No training with active tRNS stimulation
Number of subjects: 49
Study 33998818 — intervention group
Group type: COMPARATOR
Intervention: No training with sham tRNS stimulation
Number of subjects: 49
Study 32513111 — intervention group
Group type: COMPARATOR
Intervention: Caudal ropivacaine only (Control Group C)
Number of subjects: 169
Study 32513111 — intervention group
Group type: EXPERIMENTAL
Intervention: Caudal ropivacaine plus 0.25 mg/kg ketamine (Group K0.25)
Number of subjects: 169
Study 32513111 — intervention group
Group type: EXPERIMENTAL
Intervention: Caudal ropivacaine plus 0.5 mg/kg ketamine (Group K0.5)
Number of subjects: 169
Study 32513111 — intervention group
Group type: EXPERIMENTAL
Intervention: Caudal ropivacaine plus 0.75 mg/kg ketamine (Group K0.75)
Number of subjects: 169
Study 32513111 — intervention group
Group type: EXPERIMENTAL
Intervention: Caudal ropivacaine plus 1.0 mg/kg ketamine (Group K1.0)
Number of subjects: 169
Study 34801607 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance Exercise Training (RET)
Number of subjects: 62
Study 34801607 — intervention group
Group type: COMPARATOR
Intervention: Quiet-rest (WL control)
Number of subjects: 62
Study 616388369 — intervention group
Group type: EXPERIMENTAL
Intervention: Active psychological intervention based on routine nursing
Number of subjects: 100
Study 616388369 — intervention group
Group type: COMPARATOR
Intervention: Routine nursing treatment
Number of subjects: 100
Study 33584067 — intervention group
Group type: EXPERIMENTAL
Intervention: D-RIPC (donors received RIPC)
Number of subjects: 208
Study 33584067 — intervention group
Group type: COMPARATOR
Intervention: S-RIPC (no intervention)
Number of subjects: 208
Study 33584067 — intervention group
Group type: EXPERIMENTAL
Intervention: R-RIPC (recipients received RIPC)
Number of subjects: 208
Study 33584067 — intervention group
Group type: EXPERIMENTAL
Intervention: DR-RIPC (both donors and recipients received RIPC)
Number of subjects: 208
Study 32610573 — intervention group
Group type: EXPERIMENTAL
Intervention: CHO + CAF
Number of subjects: 10
Study 32610573 — intervention group
Group type: COMPARATOR
Intervention: PLA
Number of subjects: 10
Study 32610573 — intervention group
Group type: EXPERIMENTAL
Intervention: CHO
Number of subjects: 10
Study 35390535 — intervention group
Group type: EXPERIMENTAL
Intervention: Job-skills training in a contingency-management-based Therapeutic Workplace
Number of subjects: 161
Study 35390535 — intervention group
Group type: COMPARATOR
Intervention: Workdays vs. non-workdays
Number of subjects: 161
Study 34052569 — intervention group
Group type: EXPERIMENTAL
Intervention: Three 15-minute sessions of physiotherapy 5 days per week until discharge
Number of subjects: 76
Study 34052569 — intervention group
Group type: COMPARATOR
Intervention: One 45-minute session of physiotherapy 5 days per week until discharge
Number of subjects: 76
Study 35944773 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac telerehabilitation (CTR) for 10 months
Number of subjects: 56
Study 35944773 — intervention group
Group type: COMPARATOR
Intervention: Standard centre-based cardiac rehabilitation (CBCR)
Number of subjects: 56
Study 33883664 — intervention group
Group type: EXPERIMENTAL
Intervention: FIFA Quality Pro artificial turf surface
Number of subjects: 15
Study 33883664 — intervention group
Group type: COMPARATOR
Intervention: Non-certified pitch surface
Number of subjects: 15
Study 36252131 — intervention group
Group type: EXPERIMENTAL
Intervention: Finerenone
Number of subjects: 5669
Study 36252131 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5669
Study 33737321 — intervention group
Group type: EXPERIMENTAL
Intervention: eKidneyCare
Number of subjects: 182
Study 33737321 — intervention group
Group type: COMPARATOR
Intervention: MyMedRec
Number of subjects: 182
Study 33947627 — intervention group
Group type: EXPERIMENTAL
Intervention: Website engagement (intervention group)
Number of subjects: 17
Study 32650887 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise to rhythmic music intervention
Number of subjects: 20
Study 32650887 — intervention group
Group type: COMPARATOR
Intervention: Active control group (brochure with exercise instructions)
Number of subjects: 20
Study 33122168 — intervention group
Group type: EXPERIMENTAL
Intervention: Aprepitant (15-40 kg: 80 mg on days 1-3; >40 kg: 125 mg on day 1, 80 mg on days 2-3)
Number of subjects: 78
Study 33122168 — intervention group
Group type: COMPARATOR
Intervention: Ondansetron (0.15 mg/kg every 8 hours for 8 days)
Number of subjects: 78
Study 34378860 — intervention group
Group type: EXPERIMENTAL
Intervention: Internal connection with microthreads (I-MT)
Number of subjects: 25
Study 34378860 — intervention group
Group type: EXPERIMENTAL
Intervention: Internal connection without microthreads (I-NMT)
Number of subjects: 25
Study 34378860 — intervention group
Group type: EXPERIMENTAL
Intervention: External connection with microthreads (E-MT)
Number of subjects: 25
Study 34378860 — intervention group
Group type: EXPERIMENTAL
Intervention: External connection without microthreads (E-NMT)
Number of subjects: 25
Study 34378860 — intervention group
Group type: COMPARATOR
Intervention: Overall implants
Number of subjects: 25
Study 35080588 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 191
Study 35080588 — intervention group
Group type: EXPERIMENTAL
Intervention: 5.9% THC
Number of subjects: 191
Study 35080588 — intervention group
Group type: EXPERIMENTAL
Intervention: 13.4% THC
Number of subjects: 191
Study 33612484 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose insulin infusion (0.05 Unit/kg/hour)
Number of subjects: 60
Study 33612484 — intervention group
Group type: COMPARATOR
Intervention: Standard-dose insulin infusion (0.1 Unit/kg/hour)
Number of subjects: 60
Study 33090908 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote ischemic conditioning (RIC)
Number of subjects: 24
Study 33090908 — intervention group
Group type: COMPARATOR
Intervention: Sham remote ischemic conditioning (sham RIC)
Number of subjects: 24
Study 35635326 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 763
Study 33597521 — intervention group
Group type: EXPERIMENTAL
Intervention: TV003 vaccine
Number of subjects: 21
Study 32781481 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-stained cytology (CINtec PLUS assay)
Number of subjects: 492
Study 32781481 — intervention group
Group type: COMPARATOR
Intervention: HPV testing (cobas 4800 HPV Test)
Number of subjects: 492
Study 32781481 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-stained cytology combined with ASC-US threshold
Number of subjects: 492
Study 32781481 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-stained cytology combined with LSIL threshold
Number of subjects: 492
Study 32781481 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-stained cytology and HPV testing
Number of subjects: 492
Study 34907823 — intervention group
Group type: EXPERIMENTAL
Intervention: Drynaria fortunei
Number of subjects: 80
Study 34907823 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 80
Study 34118470 — intervention group
Group type: EXPERIMENTAL
Intervention: CAD/CAM device (Narval CC™)
Number of subjects: 12
Study 34118470 — intervention group
Group type: COMPARATOR
Intervention: non-CAD/CAM device (Narval™)
Number of subjects: 12
Study 32030735 — intervention group
Group type: EXPERIMENTAL
Intervention: Regional anaesthesia (brachial plexus blocks)
Number of subjects: 39
Study 32030735 — intervention group
Group type: COMPARATOR
Intervention: Local anaesthesia/mixed
Number of subjects: 39
Study 32030735 — intervention group
Group type: EXPERIMENTAL
Intervention: Supraclavicular blocks
Number of subjects: 39
Study 32030735 — intervention group
Group type: EXPERIMENTAL
Intervention: Future randomised controlled trial
Number of subjects: 39
Study 35273351 — intervention group
Group type: COMPARATOR
Intervention: BNT162b2 mRNA COVID‐19 vaccine
Number of subjects: 32